1222 related articles for article (PubMed ID: 18802025)
1. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation.
Das S; Wong R; Rajapakse N; Murphy E; Steenbergen C
Circ Res; 2008 Oct; 103(9):983-91. PubMed ID: 18802025
[TBL] [Abstract][Full Text] [Related]
2. Overcoming an energy crisis?: an adaptive role of glycogen synthase kinase-3 inhibition in ischemia/reperfusion.
Zhai P; Sadoshima J
Circ Res; 2008 Oct; 103(9):910-3. PubMed ID: 18948628
[No Abstract] [Full Text] [Related]
3. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
Mozaffari MS; Schaffer SW
Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149
[TBL] [Abstract][Full Text] [Related]
4. Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction.
Javadov S; Rajapurohitam V; Kilić A; Zeidan A; Choi A; Karmazyn M
J Mol Cell Cardiol; 2009 Jun; 46(6):998-1007. PubMed ID: 19318234
[TBL] [Abstract][Full Text] [Related]
5. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore.
Xi J; Wang H; Mueller RA; Norfleet EA; Xu Z
Eur J Pharmacol; 2009 Feb; 604(1-3):111-6. PubMed ID: 19135050
[TBL] [Abstract][Full Text] [Related]
6. Local delivery of PKCepsilon-activating peptide mimics ischemic preconditioning in aged hearts through GSK-3beta but not F1-ATPase inactivation.
Korzick DH; Kostyak JC; Hunter JC; Saupe KW
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2056-63. PubMed ID: 17675573
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore.
Obame FN; Plin-Mercier C; Assaly R; Zini R; Dubois-Randé JL; Berdeaux A; Morin D
J Pharmacol Exp Ther; 2008 Jul; 326(1):252-8. PubMed ID: 18434587
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
[TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore.
Vélez DE; Mestre-Cordero VE; Hermann R; Perego J; Harriet S; Fernandez-Pazos MLM; Mourglia J; Marina-Prendes MG
J Physiol Biochem; 2020 Feb; 76(1):85-98. PubMed ID: 31916218
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation.
Clarke SJ; Khaliulin I; Das M; Parker JE; Heesom KJ; Halestrap AP
Circ Res; 2008 May; 102(9):1082-90. PubMed ID: 18356542
[TBL] [Abstract][Full Text] [Related]
11. Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury.
Imahashi K; Schneider MD; Steenbergen C; Murphy E
Circ Res; 2004 Oct; 95(7):734-41. PubMed ID: 15345651
[TBL] [Abstract][Full Text] [Related]
12. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta.
Park SS; Zhao H; Jang Y; Mueller RA; Xu Z
J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852
[TBL] [Abstract][Full Text] [Related]
13. Xenon preconditioning: the role of prosurvival signaling, mitochondrial permeability transition and bioenergetics in rats.
Mio Y; Shim YH; Richards E; Bosnjak ZJ; Pagel PS; Bienengraeber M
Anesth Analg; 2009 Mar; 108(3):858-66. PubMed ID: 19224794
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection.
Nishihara M; Miura T; Miki T; Tanno M; Yano T; Naitoh K; Ohori K; Hotta H; Terashima Y; Shimamoto K
J Mol Cell Cardiol; 2007 Nov; 43(5):564-70. PubMed ID: 17931653
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury.
Miura T; Tanno M
Cardiovasc Drugs Ther; 2010 Jun; 24(3):255-63. PubMed ID: 20490903
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial adenine nucleotide transport and cardioprotection.
Das S; Steenbergen C
J Mol Cell Cardiol; 2012 Feb; 52(2):448-53. PubMed ID: 21945520
[TBL] [Abstract][Full Text] [Related]
17. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death.
Baines CP; Kaiser RA; Sheiko T; Craigen WJ; Molkentin JD
Nat Cell Biol; 2007 May; 9(5):550-5. PubMed ID: 17417626
[TBL] [Abstract][Full Text] [Related]
18. Translocation of glycogen synthase kinase-3β (GSK-3β), a trigger of permeability transition, is kinase activity-dependent and mediated by interaction with voltage-dependent anion channel 2 (VDAC2).
Tanno M; Kuno A; Ishikawa S; Miki T; Kouzu H; Yano T; Murase H; Tobisawa T; Ogasawara M; Horio Y; Miura T
J Biol Chem; 2014 Oct; 289(42):29285-96. PubMed ID: 25187518
[TBL] [Abstract][Full Text] [Related]
19. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.
Onishi A; Miyamae M; Kaneda K; Kotani J; Figueredo VM
Eur J Pharmacol; 2012 Jan; 675(1-3):40-6. PubMed ID: 22166375
[TBL] [Abstract][Full Text] [Related]
20. Roles of phospho-GSK-3β in myocardial protection afforded by activation of the mitochondrial K ATP channel.
Terashima Y; Sato T; Yano T; Maas O; Itoh T; Miki T; Tanno M; Kuno A; Shimamoto K; Miura T
J Mol Cell Cardiol; 2010 Nov; 49(5):762-70. PubMed ID: 20692265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
